3D Printing‐Based Polymer Nanocomposites for Cancer Treatment: Innovations and Perspectives
Bibliographic record
Abstract
Three-dimensional (3D) printing-based polymer nanocomposites have emerged as a transformative platform in cancer treatment due to their precision and ability to incorporate multifunctional features. These materials integrate biocompatible polymers with nanoscale components to create multifunctional structures that enhance drug delivery, tissue repair, and diagnostics. By incorporating nanoparticles, they enable localized treatment and improved visualization for real-time monitoring-offering a unified platform for therapy and diagnosis. By incorporating agents like liposomes, dendrimers, or magnetic nanocarriers, they achieve controlled release and tumor-specific action while minimizing systemic toxicity. In tissue engineering, these nanocomposites provide scaffolds that mimic the extracellular matrix, promoting cell adhesion, proliferation, and differentiation to repair tissues. Advanced 3D printing techniques ensure high-resolution fabrication of complex geometries tailored to individual patient needs. Polymer nanocomposites have shown significant potential in imaging applications, offering enhanced contrast in diagnostic techniques like magnetic resonance imaging, computed tomography, and fluorescence imaging. Functional nanoparticles, including quantum dots and gold nanostructures, are embedded into 3D-printed constructs to facilitate real-time tumor visualization. This multifunctionality allows the integration of therapy and diagnostics, paving the way for theranostic platforms. Furthermore, the scalability of 3D printing makes it suitable for precision medicine. Challenges remain in optimizing material properties, ensuring biocompatibility, and scaling production.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.001 | 0.000 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.000 |
| Bibliometrics | 0.001 | 0.001 |
| Science and technology studies | 0.000 | 0.001 |
| Scholarly communication | 0.002 | 0.001 |
| Open science | 0.000 | 0.000 |
| Research integrity | 0.001 | 0.001 |
| Insufficient payload (model declined to judge) | 0.002 | 0.001 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".